A Systematic Approach to Treatment-Associated Mesenchymal Stem Cells in Alzheimer’s Disease (Pages 1-9)

Marliny Bovo Mezanini1, Mateus Masson de Souza1, Carmem Costa Martins2, José Martins Pinto Neto1,3, André Wilian Lozano1,3, Luciana Estevam Simonato1,3, Wagner Rafael da Silva4, Nilton Cesar Pezati Boer1, Yolennis Infante Gonzalez5 and Rogério Rodrigo Ramos1,2

1Universidade Brasil, Fernandópolis, Brazil; 2Centro Universitário de Santa Fé do Sul (UNIFUNEC), Santa Fé do Sul, SP, Brazil; 3Fundação Educacional de Fernandópolis, Fernandópolis, Brazil; 4Department of Neuroscience and Neuropsychopharmacology, Universidade Brasil, Fernandópolis, Brazil; 5Resident Physician in the Medical Residency Program in Radiology and Diagnostic Imaging at the Brotherhood of Santa Casa da Misericórdia, Fernandópolis, Brazil

https://doi.org/10.12970/2310-8231.2021.09.01

Download PDF

Abstract: Human neurological disorders such as Alzheimer’s disease (AD), are caused by neuron loss in the central nervous system, affecting memory, learning, and is the most common cause of dementia in the elderly. Currently, the use of mesenchymal stem cell (MSC)-based technologies and therapies have become the focus of research and investigations to treat AD, due to the diverse benefits on various cellular mechanisms such as neural cell replacement and cell modulations performed in clinical trials on animal subjects, thus MSC cell therapy becomes a promising and efficient alternative therapy for the development of a reliable therapeutic tool for AD in humans. We describe through review the potential use of mesenchymal stem cells for AD treatment. This is a review, following PRISMA rules for systematic reviews. MSCs therapy has been presented as a strategy for the replacement or regeneration of neural cells for AD patients. The pre-clinical results observed are recent in MSC-based therapies, therefore, few human clinical trials are in progress, recommending more clinical human trials with MSCs for the discovery and revolution of AD, since, there is still no cure and the number of people with AD has increased in recent years.

Keywords: Mesenchymal Stem Cells, Alzheimer Disease, Clinical Trials, Infusion, Dementia.
Read more